04-28 Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-17 Shenzhen YHLO Biotech receives notice of administrative penalty from regulator RE
03-02 E-Health Now LLC announced that it has received funding from a group of investors CI
03-01 Suzhou Haohai Medical Treatment Technology Co., Ltd. announced that it has received funding from a group of investors CI
03-01 Huamei Haolian Medical Technology Co., Ltd. announced that it has received funding from a group of investors CI
02-27 Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-07 YHLO Biotech Discloses 'Uncertainty' Stemming From Recent Partnership With Brain-Machine Starlink MT
12-24 Shenzhen YHLO Biotech Subsidiary Gets Chinese Provincial-Level Approval for Two Diagnostic Kits MT
12-16 Shenzhen YHLO Biotech Gets Chinese Provincial Regulator's Approval for Two Autoimmune Disease Testing Kits MT
11-28 YHLO Biotech Gets Dutch Certification for HIV Kit MT
11-26 YHLO Biotech Gets Guangdong Registrations for sST2 Test Kit, Microfluidic Analyzer MT
11-20 Shenzhen YHLO Biotech Gets Guangdong Approval for Immunoassay Analyzer MT
11-18 Shenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit MT
11-07 YHLO Biotech Gets Registration Certificate for Human Chorionic Gonadotropin Kit MT
29/10/25 Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
11/09/25 YHLO Biotech's Controlling Shareholder Trims Stake MT
25/08/25 Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
18/08/25 Shenzhen YHLO Biotech's shareholders to unload shares RE
26/05/25 Declaration of Voting Results by Shenzhen YHLO Biotech CI
17/05/25 Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2025. CI
15/05/25 Shenzhen YHLO Biotech Receives Shareholder Proposal from Kunhui Hu CI
24/04/25 Shenzhen YHLO Biotech Co., Ltd. announces Annual dividend, payable on June 27, 2025 CI
24/04/25 Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
17/03/25 Shenzhen YHLO Biotech Gets China Copyright Nod for Diabetes Diagnosis Software MT
27/02/25 Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
No results for this search
  1. Stock Market
  2. Equities
  3. 688575 Stock
  4. News Shenzhen YHLO Biotech Co., Ltd.